Diabetes Care 42(9):16371644
What this post covers: Where GLP-1 receptors sit in the brain and why that matters for reward and compulsion The clinical trial pipeline for GLP-1 agonists in addiction (alcohol, nicotine, opioids) Why anhedonia may be a dosing problem, not a drug problem, and the ziprasidone parallel Real-world observations from low-dose tirzepatide combined with ketogenic diets The scope-of-practice question: should psychiatrists be prescribing GLP-1 agonists
Check the vial label to make sure you have the right medicine and dose, and that it has not expired
Peptide therapy is an emerging medical practice that uses specific peptides, such as BPC-157, to aid tissue repair, improve joint health, increase exercise capacity, and enhance overall health and wellness
Semaglutide is a medication used to treat type 2 diabetes and to help with weight loss in people who are overweight or obese